However, SMYD5 expression data for normal tissues were not available for several cancers in TCGA, such as adrenocortical carcinoma (ACC), diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), lower-grade glioma (LGG), ovarian cancer (OV), sarcoma (SARC), testicular germ cell tumors (TGCT), thymoma (THYM), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS). Here, SMYD5 is linked to central nervous system cancer.